Abstract
Metformin has been reported to reduce the risk of gestational diabetes (GD) in women with polycystic ovarian syndrome (PCOS). However, little is known about the mechanisms of action of this drug during pregnancy. In the attempt to fill this gap, we performed a prospective longitudinal study providing a detailed examination of glucose and insulin metabolism in pregnant women with PCOS undergoing metformin therapy.
Lingua originale | Inglese |
---|---|
pagine (da-a) | 1477-1482 |
Numero di pagine | 6 |
Rivista | Diabetes Care |
Volume | 36 |
Numero di pubblicazione | 6 |
DOI | |
Stato di pubblicazione | Pubblicato - 2013 |
Pubblicato esternamente | Sì |
All Science Journal Classification (ASJC) codes
- Medicina Interna
- Endocrinologia, Diabete e Metabolismo
- Infermieristica Avanzata e Specializzata
Keywords
- Adolescent
- Adult
- Female
- Humans
- Hypoglycemic Agents
- Insulin
- Metformin
- Polycystic Ovary Syndrome
- Pregnancy
- Pregnancy Trimesters
- Prospective Studies
- Young Adult